Skip to content
Open access

Lung Multidisciplinary Team Decision-Making Challenges in Perioperative NSCLC: Borderline Resectability and Discordant Responses Through the Lens of Real-World Scenarios

Oct 2026 · Cancers · Vol 18 · 0 citations · 55 references
Medicine

Abstract

Simple Summary The management of stage II–III non-small cell lung cancer has become increasingly complex with the introduction of preoperative and perioperative systemic treatments, molecular testing, and more individualized surgical strategies. This study aims to understand how treatment plans are actually selected and adapted in routine multidisciplinary practice, focusing on the main points at which the initial strategy changes. We retrospectively analyzed 101 consecutive patients with stage II–III disease discussed by a thoracic multidisciplinary team between 2023 and 2025. The analysis identified three major decision points: selection of preoperative treatment, reassessment of eligibility for surgery, and feasibility of postoperative treatment. The findings show that treatment pathways are often modified because of disease response, progression, surgical feasibility, comorbidities, treatment toxicity, or postoperative recovery. These observations support a longitudinal and adaptive multidisciplinary approach and may help identify clinical and organizational areas where perioperative care can be further improved. The study describes treatment feasibility without comparing the efficacy of different therapeutic strategies.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.